| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/13/2005 | CN1606441A Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 04/13/2005 | CN1606438A 5HT4 partial agonist pharmaceutical compositions |
| 04/13/2005 | CN1606437A Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
| 04/13/2005 | CN1606435A Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 04/13/2005 | CN1606434A Release control type formed product |
| 04/13/2005 | CN1606433A Methods for wet granulating azithromycin |
| 04/13/2005 | CN1606432A Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 04/13/2005 | CN1606430A Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 04/13/2005 | CN1606427A Stable surfactant compositions for suspending components |
| 04/13/2005 | CN1606406A Mitocidal compositions and methods |
| 04/13/2005 | CN1605367A Surface treatment method and instrument of air bubble utilizing backing |
| 04/13/2005 | CN1605359A Method for preparing embedded hydrophilic medicinal polymer minisphere or minisac carrier |
| 04/13/2005 | CN1605356A Preparation process and prescription of oleum fructus bruceae containing microemulsion |
| 04/13/2005 | CN1605355A Snuffle dredging capsule |
| 04/13/2005 | CN1605354A Yang strengthening capsule and its preparation |
| 04/13/2005 | CN1605353A Liniment for diminishing inflammation and stopping pain and its preparation process |
| 04/13/2005 | CN1605352A Plaster for treating hyperplasia of mammary glands |
| 04/13/2005 | CN1605351A Preparation process and novel application of Laiyang pear buccal tablet and other oral formulation |
| 04/13/2005 | CN1605350A Medicine for treating hyperosteogeny |
| 04/13/2005 | CN1605347A Preparation and application of red rice dispersible tablet |
| 04/13/2005 | CN1605343A Application of skimming in the preparing process of medicine for preparing and treating kidney function failure |
| 04/13/2005 | CN1605342A Breviscapine injection for perfusion and its preparing process |
| 04/13/2005 | CN1605337A Application of cnidium fruit element in the preparing process of medicine for preventing and treating Sexual dysfunction |
| 04/13/2005 | CN1605334A Usage of composition in preparing medicine for tumorous disease treatment |
| 04/13/2005 | CN1605332A Fibrauretine injection for perfusion and its preparing process |
| 04/13/2005 | CN1605294A Compound tobacco addict controlling plaster and its preparation method |
| 04/13/2005 | CN1196498C Preparing box for polysaccharide compounding substance |
| 04/13/2005 | CN1196494C Medicine powder for aphtha of external use |
| 04/13/2005 | CN1196491C Ointment for healing trauumatic injury |
| 04/13/2005 | CN1196489C Perfusion liquid preparations for ophthalmic operations |
| 04/13/2005 | CN1196487C 单位剂量形式 The unit dosage form |
| 04/13/2005 | CN1196486C Ziprasidone suspension liquid |
| 04/13/2005 | CN1196483C Compositions for improivng fertility |
| 04/13/2005 | CN1196481C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/13/2005 | CN1196479C Use of benzidine prostaglandins of inhalation form |
| 04/13/2005 | CN1196478C Combinations of formoterol and mometasone furoate for asthma |
| 04/13/2005 | CN1196477C Pharmaceutical compsition for oral delivery |
| 04/13/2005 | CN1196476C Production method of oral cavitity quickly disintegrating tablets |
| 04/13/2005 | CN1196475C Bioavailable dosage form of isotretinoin |
| 04/13/2005 | CN1196474C Liposome-entrapped DNA oral vaccines |
| 04/13/2005 | CN1196472C Bacterial Chinese medical preparation and preparing method thereof |
| 04/12/2005 | US6878826 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
| 04/12/2005 | US6878758 Polyhydroxyalkanoate compositions having controlled degradation rates |
| 04/12/2005 | US6878751 Administration of resveratrol to treat inflammatory respiratory disorders |
| 04/12/2005 | US6878749 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/12/2005 | US6878747 Systemic formulations containing beta-carotene and derivatives thereof |
| 04/12/2005 | US6878698 Anti-inflammatory androstane derivatives |
| 04/12/2005 | US6878694 Ophthalmic irrigating solution adapted for use in lasik surgery |
| 04/12/2005 | US6878693 Hydrophilic complexes of lipophilic materials and an apparatus and method for their production |
| 04/12/2005 | US6878548 Composition for use in electroporation |
| 04/12/2005 | US6878387 Core with an organic acid salt; acrylic blend coating of an interpolymer of a (meth)acrylate ester and a quaternary ammonium (meth)acrylate and a (meth)acrylate ester homo- or copolymer with an ester having acid or base groups |
| 04/12/2005 | US6878386 Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
| 04/12/2005 | US6878384 A polymeric hydrogel material that permits cellular ingrowth and has controlled rate of expansion optimized for delivery through microcatheter or catheter without need for a nonaqueous solvent or coating |
| 04/12/2005 | US6878365 Topical application for treating toenail fungus |
| 04/12/2005 | US6877249 Vacuum chamber at elevated temperature so that the solution forms a foam, drying, milling or grinding or breaking the dried foam into powder |
| 04/12/2005 | CA2385854C Formulation for menopausal women |
| 04/12/2005 | CA2337745C Human growth hormone aqueous formulation |
| 04/12/2005 | CA2257172C Dissolvable oxides for biological applications |
| 04/12/2005 | CA2250704C Glial cell line-derived neurotrophic factor receptor |
| 04/12/2005 | CA2179180C Depth-type filter for killing microorganisms and inactivating viruses and its use |
| 04/12/2005 | CA2143044C Matrix for sustained-release preparation |
| 04/12/2005 | CA2142445C Injection solutions of azosemide which are ready for injection |
| 04/12/2005 | CA2123363C Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/12/2005 | CA2109451C Absorbable block copolymers and surgical articles made therefrom |
| 04/12/2005 | CA2101742C Biodegradable polymer blends for drug delivery |
| 04/10/2005 | CA2702138A1 Sustained-release tramadol formulations with 24-hour clinical efficacy |
| 04/07/2005 | WO2005030835A1 Polyethylene glycol derivatives and drug carriers containing the same as the membrane constituent |
| 04/07/2005 | WO2005030476A1 Three-dimensional gels that have microscale features |
| 04/07/2005 | WO2005030383A1 Encapsulated products |
| 04/07/2005 | WO2005030331A1 Combination antihistamine medication |
| 04/07/2005 | WO2005030248A1 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
| 04/07/2005 | WO2005030247A1 Altering animal waste composition |
| 04/07/2005 | WO2005030236A1 Substance having intrahepatic glyconeogenesis inhibiting activity and food or food additive containing the substance |
| 04/07/2005 | WO2005030229A1 Probiotic storage and delivery |
| 04/07/2005 | WO2005030226A1 Compositions and methods of using lamellar bodies for therapeutic purposes |
| 04/07/2005 | WO2005030221A1 Therapeutic agent for ageing macular degeneration |
| 04/07/2005 | WO2005030220A1 Pulmonary disease treatment |
| 04/07/2005 | WO2005030219A1 Method of stabilizing diarylvinylene compound |
| 04/07/2005 | WO2005030211A1 Aerosol formulation for inhalation, containing an anticholinergic agent |
| 04/07/2005 | WO2005030205A1 Ocular solutions containing a macrolide antibiotic and/or mycophenolic acid |
| 04/07/2005 | WO2005030201A1 Sustained release preparation containing hydrochlorothiazide |
| 04/07/2005 | WO2005030195A1 (-)-hydroxycitric acid for delaying gastric emptying |
| 04/07/2005 | WO2005030190A1 Natural menaquinone 7 compositions |
| 04/07/2005 | WO2005030183A2 A method for the preparation of atorvastatin calcium tablets |
| 04/07/2005 | WO2005030182A1 Controlled release formulations exhibiting an ascending rate of release |
| 04/07/2005 | WO2005030181A1 Controlled release formulations of opioid and nonopioid analgesics |
| 04/07/2005 | WO2005030180A1 Osmotic dosage forms for controlled delivery of alprazolam |
| 04/07/2005 | WO2005030179A1 Sustained-release formulations |
| 04/07/2005 | WO2005030178A1 Extended release formulation of beta-lactam antibiotics |
| 04/07/2005 | WO2005030177A2 Pharmaceutical formulation with improved stability |
| 04/07/2005 | WO2005030176A1 Improved stability of progestogen formulations |
| 04/07/2005 | WO2005030175A1 Hrt formulations |
| 04/07/2005 | WO2005030174A1 Ph-triggered microparticles |
| 04/07/2005 | WO2005030173A1 Colon-specific drug delivery using interpolymer complexations |
| 04/07/2005 | WO2005030172A1 Antimicrobial nanoemulsion compositions and methods |
| 04/07/2005 | WO2005030171A1 Delivery of therapeutic compounds via microparticles or microbubbles |
| 04/07/2005 | WO2005030170A2 Controlled rupture of furtive liposomes |
| 04/07/2005 | WO2005030169A1 Methods for preparing oil bodies comprising active ingredients |
| 04/07/2005 | WO2005030168A1 Skin burn treatment ointment |
| 04/07/2005 | WO2005030167A2 Buccal, polar and non-polar spray containing alprazolam |